Literature DB >> 15485747

Out-of-office blood pressure in children and adolescents: disparate findings by using home or ambulatory monitoring.

George S Stergiou1, Christina V Alamara, Chrysa B Kalkana, Iraklis N Vaindirlis, Constantinos J Stefanidis, Catherine Dacou-Voutetakis, Theodore D Mountokalakis.   

Abstract

BACKGROUND: The validity of home blood pressure (HBP) measurements in children has not been evaluated, although in clinical practice such measurements are being used. This study compares HBP, with clinic (CBP) and daytime ambulatory blood pressure (ABP) in children and adolescents.
METHODS: Fifty-five children and adolescents aged 6 to 18 years were evaluated with CBP (three visits), HBP (6 days), and daytime ABP. Mean age was 12.3 +/- 2.9 (SD) years, 33 boys. According to the Task Force CBP criteria, 26 were hypertensives, 6 had high-normal BP (hypertensive group), and 23 were normotensives (normotensive group).
RESULTS: In the hypertensive group, CBP was 130.8 +/- 7.6/72.5 +/- 8.1 mm Hg (systolic/diastolic), HBP 118.9 +/- 6.3/73.7 +/- 6.7, and ABP 130.8 +/- 8.1/75.5 +/- 8.3. In the normotensive group, CBP was 112.8 +/- 8/63.1 +/- 6.3, HBP 106.7 +/- 8.4/67.2 +/- 5.2, and ABP 123.9 +/- 7.2/72 +/- 4.3. Strong correlations (P < .001) were observed between CBP-HBP (r = 0.73/0.57, systolic/diastolic), CBP-ABP (r = 0.59/0.49), and HBP-ABP (r = 0.72/0.66). In normotensive subjects, ABP was higher than both CBP and HBP for systolic and diastolic BP (P < .001). Furthermore, systolic HBP was lower than CBP (P < .01), whereas the opposite was true for diastolic BP (P < .05). In hypertensive subjects systolic HBP was lower than both CBP and ABP (P < .001), whereas CBP did not differ from ABP. For diastolic BP no differences were found among measurement methods.
CONCLUSIONS: These data suggest that, in contrast to adults in whom HBP is close to the levels of daytime ABP, in children and adolescents HBP appears to be significantly lower than daytime ABP. Until more data become available, caution is needed in the interpretation of HBP in children and adolescents.

Entities:  

Mesh:

Year:  2004        PMID: 15485747     DOI: 10.1016/j.amjhyper.2004.05.015

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

Review 1.  Utility of ambulatory blood pressure monitoring in children and adolescents.

Authors:  John W Graves; Mohammed Mahdi Althaf
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

2.  The definition of daytime and nighttime influences the interpretation of ABPM in children.

Authors:  Helen E Jones; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2011-02-14       Impact factor: 3.714

3.  Home Blood Pressure Monitoring in Children and Adolescents: Systematic Review of Evidence on Clinical Utility.

Authors:  George Stergiou; Emelina Stambolliu; Ioanna Bountzona; Angeliki Ntineri; Anastasios Kollias; Andriani Vazeou; Alexandra Soldatou
Journal:  Curr Hypertens Rep       Date:  2019-06-25       Impact factor: 5.369

4.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

Review 5.  Pediatric ambulatory blood pressure monitoring: indications and interpretations.

Authors:  Joseph T Flynn; Elaine M Urbina
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-07       Impact factor: 3.738

6.  Home Blood Pressure Monitoring as an Alternative to Confirm Diagnoses of Hypertension in Adolescents with Elevated Office Blood Pressure from a Brazilian State Capital.

Authors:  Thaís Inacio Rolim Póvoa; Thiago Veiga Jardim; Carolina de Souza Carneiro; Vanessa Roriz Ferreira; Karla Lorena Mendonça; Polyana Resende Silva de Morais; Flávia Miquetichuc Nogueira Nascente; Weimar Kunz Sebba Barroso de Souza; Ana Luiza Lima Sousa; Paulo César Brandão Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2017-08-07       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.